|
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin
|
Lamorde, M.; Byakika-Kibwika, P.; Okaba-Kayom, V.; Ryan, M.; Coakley, P.; Boffito, M.; Namakula, R.; Kalemeera, F.; Colebunders, R.; Back, D.; Khoo, S.; Merry, C.
|
Journal of Antimicrobial Chemotherapy |
2011
|
Article
|